Search Results

Filter
  • 1-10 of  143 results for ""Tegafur""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer.

  • Authors : Cui H; Medical School of Chinese People's Liberation Army (PLA), Beijing, China (mainland).; Department of Oncology, The Eighth Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China (mainland).

Subjects: Albumins*/Albumins*/Albumins*/adverse effects ; Albumins*/Albumins*/Albumins*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Oct 26; Vol. 26, pp. e927654. Date of Electronic Publication: Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 9609063 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A two centers study of postoperative adjuvant chemotherapy with S-1 versus SOX/XELOX regimens for gastric cancer after D2 resection: a cohort study.

  • Authors : Zheng S; Department of Oncology, Hangzhou First People's Hospital, Hangzhou Cancer Hospital, Zhejiang University School of Medicine Affiliated Hangzhou First People's Hospital, Nanjing Medical University Affiliated Hangzhou Hospital, Zhejiang Chinese Medical University Affiliated Hangzhou First Hospital, Hangzhou, 310006, China. .; Zhou Y

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Capecitabine*/Capecitabine*/Capecitabine*/administration & dosage XELOX

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Oct; Vol. 84 (4), pp. 819-827. Date of Electronic Publication: 2019 Aug 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China.

Subjects: Oxaliplatin/Oxaliplatin/Oxaliplatin/*therapeutic use ; Oxonic Acid/Oxonic Acid/Oxonic Acid/*therapeutic use ; Stomach Neoplasms/Stomach Neoplasms/Stomach Neoplasms/*drug therapy

  • Source: Medicine [Medicine (Baltimore)] 2019 May; Vol. 98 (20), pp. e15696.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study.

  • Authors : Jiang Z; Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. No, 17, Panjiayuannanli Street, Chaoyang District, Beijing, 100021, China.; Zhou A

Subjects: Esophagogastric Junction*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Oxaliplatin/Oxaliplatin/Oxaliplatin/*administration & dosage

  • Source: BMC cancer [BMC Cancer] 2022 Mar 09; Vol. 22 (1), pp. 253. Date of Electronic Publication: 2022 Mar 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Editorial & Opinion

CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients.

  • Authors : Yang L; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: .; Zou S

Subjects: Asian People/Asian People/Asian People/*genetics ; Cytochrome P-450 CYP2A6/Cytochrome P-450 CYP2A6/Cytochrome P-450 CYP2A6/*genetics ; Organoplatinum Compounds/Organoplatinum Compounds/Organoplatinum Compounds/*therapeutic use

  • Source: Genomics, proteomics & bioinformatics [Genomics Proteomics Bioinformatics] 2017 Aug; Vol. 15 (4), pp. 255-262. Date of Electronic Publication: 2017 Aug 12.Publisher: Science Press and Elsevier Country of Publication: China NLM ID: 101197608 Publication Model: Print-Electronic

Record details

×
Academic Journal

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.

  • Authors : Wang HY; Department of Medical Oncology of Henan Cancer Hospital, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, Henan, China.; Yao ZH

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy ; Cisplatin/Cisplatin/Cisplatin/*administration & dosage

  • Source: Oncotarget [Oncotarget] 2017 Jan 31; Vol. 8 (5), pp. 7540-7547.Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.

  • Authors : Wu FL; From the Hospital Quality Management Office (F-LW); Department of Endocrinology (D-CL, A-MZ, XY, JZ, H-QH)

Subjects: Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Fluorouracil/Fluorouracil/Fluorouracil/*analogs & derivatives ; Fluorouracil/Fluorouracil/Fluorouracil/*therapeutic use

  • Source: Medicine [Medicine (Baltimore)] 2015 Apr; Vol. 94 (16), pp. e652.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  143 results for ""Tegafur""